Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

416
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
416
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

472
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
472
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

480
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
480
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

514
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
514
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

374
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
374
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

6.2K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Metabolic dysfunction-associated steatotic liver disease accelerates pancreatic cancer progression and metastasis via the macrophage migration inhibitory factor-CD44 axis.

Signal transduction and targeted therapy·2026
Same author

Plumbagin Triggers STING Pathway Activation to Suppress Non-Small Cell Lung Cancer Progression.

Chemical biology & drug design·2025
Same author

Tumor necrosis factor alpha-induced protein 3: A key biomarker for response to ursodeoxycholic acid in primary biliary cholangitis.

World journal of hepatology·2025
Same author

Gut Microbiota Combined With Metabolomics to Reveal the Mechanism of Tang Wang Ming Mu Granule in the Treatment of Diabetic Retinopathy in Mice.

Biomedical chromatography : BMC·2025
Same author

Celastrol inhibits the DPYSL2-JAK/STAT pathway by targeting mito-IDHs mediated mitochondrial metabolism to exhaust breast cancer.

Acta pharmacologica Sinica·2025
Same author

NSCLC cells sustain phase separation of cytoplasmic membrane-less organelles to protect themselves against cisplatin treatment.

Acta pharmacologica Sinica·2025
Same journal

Late outcomes of postoperative complete heart block after congenital heart surgery: recovery or re-heart block?

The Annals of thoracic surgery·2026
Same journal

Coronary artery bypass grafting based on computed tomography-derived fractional flow reserve versus angiography: Early results.

The Annals of thoracic surgery·2026
Same journal

Beyond R0: Margin Cytology and Local Control After Sublobar Resection.

The Annals of thoracic surgery·2026
Same journal

Deferred AVR During CABG in Moderate Aortic Stenosis: Lower Index Risk or Deferred Cumulative Risk?

The Annals of thoracic surgery·2026
Same journal

The Renaissance of Transapical TAVR: From Competing Access Route to Enabling Platform for Hybrid Heart Therapy.

The Annals of thoracic surgery·2026
Same journal

A Moving Target: Interpreting Post-TAVI Reintervention in a Rapidly Evolving Era.

The Annals of thoracic surgery·2026
See all related articles

Related Experiment Video

Updated: Jan 18, 2026

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

2.6K

Primary cardiac synovial sarcoma.

Ji-Gang Wang1, Ning-Ning Li

  • 1Department of Pathology, The Affiliated Hospital of Medical College, Qingdao University, Qingdao, China. qdwangjigang@hotmail.com

The Annals of Thoracic Surgery
|May 8, 2013
PubMed
Summary
This summary is machine-generated.

Primary cardiac synovial sarcoma is a rare tumor with unknown prognostic factors. This study reviews patient data to summarize key features for diagnosis and treatment.

More Related Videos

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
07:15

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

Published on: July 28, 2020

10.2K
Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas
09:21

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas

Published on: September 13, 2019

7.6K

Related Experiment Videos

Last Updated: Jan 18, 2026

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

2.6K
A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
07:15

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

Published on: July 28, 2020

10.2K
Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas
09:21

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas

Published on: September 13, 2019

7.6K

Area of Science:

  • Cardiovascular Pathology
  • Oncology
  • Rare Tumors

Background:

  • Primary cardiac synovial sarcoma is exceptionally rare.
  • Its clinical and pathological characteristics are not well-understood.
  • Prognostic factors affecting patient survival remain largely unknown.

Purpose of the Study:

  • To review and summarize the clinical and pathological features of primary cardiac synovial sarcoma.
  • To analyze survival data and identify potential prognostic factors.
  • To provide guidance for the diagnosis and treatment of this rare tumor.

Main Methods:

  • Comprehensive review of all reported patient cases.
  • Inclusion of data on demographics, clinical presentation, diagnostics (laboratory, ECG, imaging), pathology, tumor location, treatment, and follow-up.
  • Performance of survival analysis on collected data.

Main Results:

  • Summarization of key characteristics of primary cardiac synovial sarcoma.
  • Identification of patterns in patient data, clinical presentations, and treatment outcomes.
  • Preliminary insights into factors potentially influencing survival.

Conclusions:

  • The study consolidates current knowledge on primary cardiac synovial sarcoma.
  • It offers a valuable resource for clinicians managing this rare malignancy.
  • Further research is needed to fully elucidate prognostic factors and optimize therapeutic strategies.